Worth Venture Partners’s Aravive, Inc. Common Stock ARAV Stock Holding History

Worth Venture Partners’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-50	Closed	-$6K	–	151
2017 Q3	$6K	Buy	+50	New	+$5.04K	0.01%	119

Other funds holding ARAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Worth Venture Partners's ARAV Position: Q4 2017 in Review

Worth Venture Partners sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2017, closing a stake of 50 shares.

Worth Venture Partners first reported a position in ARAV in Q3 2017 and held it in 1 quarter. The position peaked at $0 in Q3 2017. 85 funds tracked by Wall St. Rank hold ARAV as of Q4 2017.

Worth Venture Partners reported no remaining Aravive, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Worth Venture Partners sold 50 Aravive, Inc. Common Stock shares in Q4 2017.
Worth Venture Partners first reported a position in Aravive, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
Worth Venture Partners's Aravive, Inc. Common Stock position peaked at $0 in Q3 2017.
85 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2017.

Based on Worth Venture Partners's 13F filing for Q4 2017, filed 1 Feb 2018.